Heparin-coated cardiopulmonary bypass circuit: Clinical effects in pediatric cardiac surgery

被引:16
|
作者
Miyaji, K [1 ]
Hannan, RL [1 ]
Ojito, J [1 ]
Jacobs, JP [1 ]
White, JA [1 ]
Burke, RP [1 ]
机构
[1] Miami Childrens Hosp, Dept Cardiovasc Surg, Miami, FL USA
关键词
D O I
10.1111/j.1540-8191.2000.tb00456.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Heparin-coated cardiopulmonary bypass (CPB) circuits have been reported to reduce complement activation and the inflammatory response associated with CPB. We retrospectively compared patients utilizing heparin-coated perfusion circuits with those using noncoated circuits to determine the clinical effects of the different circuits in pediatric cardiac surgery. Methods: Between July 1995 and July 1997, 203 patients weighing < 10 kg underwent cardiac surgery, 153 patients using heparin-coated bypass circuits and 50 patients using noncoated circuits. The 50 patients operated on with the noncoated circuit (Group N) were matched to 100 patients operated on with coated circuits (Group H) in age, weight, and type of procedure. Urine output during bypass, blood products used after bypass, postoperative ventilation days, hospital stay, morbidity, and mortality were compared between these groups. Results: Body weight, perfusion time, and procedure time were not different between the two groups. Urine output during bypass was notably greater in Group H than in Group hi (11.3 +/- 10.5 mL/kg per hour vs 4.8 +/- 3.1 mL/kg per hour, respectively, p < 0.0001). Postoperative mechanical ventilation markedly decreased in Group H (Group H vs hi = 2.8 +/- 2.7 days vs 5.1 +/- 7.5 days, respectively, p < 0.05). Red blood cell usage, hospital stay, morbidity, and mortality were not statistically different, although there was a tendency toward decreased transfusion of red cell and platelets in Group H (Group H vs N = 61.2 +/- 121.1 mL/kg vs 102.0 +/- 176.7 mL/kg, respectively, in red cell, p = 0.15; and Group H vs hi = 7.9 +/- 13.7 mL/kg vs 13.2 +/- 24.5 mL/kg, respectively, in platelets, p = 0.16). Conclusions: Patients operated on with the use of heparin-coated circuits had increased urine output during bypass and required less time postoperatively on the ventilator. These results suggest a reduction in the acute inflammatory response, capillary leakage, and overall systemic edema. We now routinely use coated circuits on all pediatric pump cases.
引用
收藏
页码:194 / 198
页数:5
相关论文
共 50 条
  • [21] HEPARIN-COATED CIRCUITS REDUCE THE INFLAMMATORY RESPONSE TO CARDIOPULMONARY BYPASS
    GU, YJ
    VANOEVEREN, W
    AKKERMAN, C
    BOONSTRA, PW
    HUYZEN, RJ
    WILDEVUUR, CRH
    ANNALS OF THORACIC SURGERY, 1993, 55 (04): : 917 - 922
  • [22] Clinical effects of the heparin coated surface in cardiopulmonary bypass
    Svenmarker, S
    Sandstrom, E
    Karlsson, T
    Jansson, E
    Haggmark, S
    Lindholm, R
    Appelblad, M
    Aberg, T
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1997, 11 (05) : 957 - 964
  • [23] Clinical study of biocompatibility between open and closed heparin-coated cardiopulmonary bypass circuits
    Hiroyuki Tanaka
    Takanori Oshiyama
    Takashi Narisawa
    Takanobu Mori
    Mikio Masuda
    Daijirou Kishi
    Takashi Kitou
    Shingo Miyazima
    Journal of Artificial Organs, 2003, 6 (4) : 245 - 252
  • [24] Efficacy of a Heparin-Coated Closed Circuit for Intractable Bleeding in Adult Cardiac Surgery
    Takai, Hideaki
    Kobayashi, Junjiro
    Nakajima, Hiroyuki
    Tagusari, Osamu
    Niwaya, Kazuo
    Nakatani, Takeshi
    Yagihara, Toshikatsu
    Kitamura, Soichiro
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 16 (02) : 131 - 133
  • [25] HEPARIN-COATED CIRCUIT DURING CARDIOPULMONARY BYPASS - A CLINICAL-STUDY USING CLOSED-CIRCUIT, CENTRIFUGAL PUMP AND REDUCED HEPARINIZATION
    SELLEVOLD, OFM
    BERG, TM
    REIN, KA
    LEVANG, OW
    IVERSEN, OJ
    BERCH, K
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1994, 38 (04) : 372 - 379
  • [26] Low-molecular-weight heparin-coated cardiopulmonary bypass: coagulatory and clinical findings
    N Mirow
    T Brinkmann
    N Reiβ
    G Kleikamp
    K Kleesiek
    R Körfer
    Critical Care, 5 (Suppl 7):
  • [27] DELETERIOUS EFFECTS OF CARDIOPULMONARY BYPASS ON EARLY GRAFT FUNCTION AFTER SINGLE-LUNG ALLOTRANSPLANTATION - EVALUATION OF A HEPARIN-COATED BYPASS CIRCUIT
    FRANCALANCIA, NA
    AEBA, R
    YOUSEM, SA
    GRIFFITH, BP
    MARRONE, GC
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1994, 13 (03): : 498 - 507
  • [28] A prospective randomized trial comparing the clinical effectiveness and biocompatibility of heparin-coated circuits and PMEA-coated circuits in pediatric cardiopulmonary bypass
    Itoh, Hideshi
    Ichiba, Shingo
    Ujike, Yoshihito
    Douguchi, Takuma
    Kasahara, Shingo
    Arai, Sadahiko
    Sano, Shunji
    PERFUSION-UK, 2016, 31 (03): : 247 - 254
  • [29] A heparin-coated circuit maintains platelet aggregability in response to shear stress in an in vitro model of cardiopulmonary bypass
    Hioki, I
    Nishikawa, M
    Onoda, K
    Shimono, T
    Shimpo, H
    Tanaka, K
    Suzuki, Y
    Shiku, H
    Ikeda, Y
    Yada, I
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (03) : 437 - 442
  • [30] Experimental studies on three types of heparin-coated cardiopulmonary bypass circuits
    Baba, T
    Morisita, K
    Sakata, J
    Ito, T
    Hachiro, Y
    Kazui, T
    Abe, A
    Komatu, S
    ARTIFICIAL ORGANS, 1997, 21 (07) : 779 - 781